CIK 0001651308
- Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 981209416
- Phone
- +41 616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-05-06 | Liang Howard CFO & Chief Strategy Officer | Sale | −1,800 | $130.01 | $234K | 0 |
| 2019-05-06 | Liang Howard CFO & Chief Strategy Officer | Exercise or conversion · Share Option (Right to Buy) | +23,400 | 4,421,600 | ||
| 2019-05-01 | Wu Xiaobin President & GM China | Sale | −185 | $125.43 | $23K | 23,135 |
| 2019-05-01 | Wu Xiaobin President & GM China | Sale | −5,657 | $124.47 | $704K | 17,478 |
| 2019-05-01 | Wu Xiaobin President & GM China | Sale | −113 | $125.55 | $14K | 17,365 |
| 2019-05-01 | OYLER JOHN Chief Executive Officer | Sale | −1,402 | $124.79 | $175K | 1,422 |
| 2019-05-01 | OYLER JOHN Chief Executive Officer | Sale | −1,371 | $125.53 | $172K | 51 |
| 2019-05-01 | OYLER JOHN Chief Executive Officer | Sale | −51 | $126.54 | $6K | 0 |
| 2019-04-08 | Huang Jane CMO, Hematology | Exercise or conversion | +14,130 | $29.49 | $417K | 14,130 |
| 2019-04-08 | Huang Jane CMO, Hematology | Sale | −800 | $140.49 | $112K | 13,330 |
| 2019-04-08 | Huang Jane CMO, Hematology | Sale | −3,439 | $141.80 | $488K | 9,891 |
| 2019-04-08 | Huang Jane CMO, Hematology | Sale | −6,159 | $142.73 | $879K | 3,732 |
| 2019-04-08 | Huang Jane CMO, Hematology | Sale | −2,304 | $143.72 | $331K | 1,428 |
| 2019-04-08 | Huang Jane CMO, Hematology | Sale | −1,281 | $144.90 | $186K | 147 |
| 2019-04-08 | Huang Jane CMO, Hematology | Sale | −147 | $145.94 | $21K | 0 |
| 2019-04-08 | Huang Jane CMO, Hematology | Exercise or conversion · Share Option (Right to Buy) | +183,690 | 1,111,465 | ||
| 2019-03-14 | Glazer Donald W. Director | Sale | −14,973 | $136.10 | $2.0M | 0 |
| 2019-03-13 | Wang Xiaodong Director | Gift | −18,577 | 7,677,031 | ||
| 2019-03-13 | Wang Xiaodong Director | Gift | −2,392 | 7,674,639 | ||
| 2019-03-11 | Huang Jane CMO, Hematology | Exercise or conversion | +2,565 | $29.49 | $76K | 2,565 |
Page 103 of 123 · 2,455 trades